| |
|
|
|
HTG Molecular Diagnostics Inc.  
|
|
0.7833 -0.007 (-0.01%) |
10-16 16:00 |
|
Open: |
0.794 |
Pre close: |
0.79 |
Target:
|
1.05
|
|
High: |
0.81 |
Low: |
0.7702 |
Resistance:
|
0.90
1.05
|
|
Volume: |
80,859 |
Market Cap: |
45M |
Support:
|
0.71
0.60
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.82
 |
MACD |
MACD(12,26):
|
-0.02 |
|
MA(20): |
0.77 |
Signal(12,26,9): |
-0.03  |
|
MA(100): |
1.29 |
Stochastic Oscillator |
%K(14,3):
|
67.03 |
|
MA(250): |
2.17 |
%D(3): |
73.83 |
|
Average Volume(K) |
3-Month: |
30406
|
52-Week |
High:
|
4.27 |
|
10-Days: |
33015 |
Low: |
0.60 |
|
RSI |
RSI(14):
|
45.31 |
Change(%): |
-78.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.600 |
Return on Equity (ttm) |
-88.2 |
Shares Out. (M) |
28.72 |
|
EPS Est. Current Year |
-2.290 |
Return on Assets (ttm) |
-25.1 |
Shares Float (M) |
22.43 |
|
EPS Est. Next Year |
-1.720 |
PEG Ratio |
0.00 |
% Held by Insiders |
7.75 |
|
EPS Est. Next Quarter |
-0.480 |
Qtrly Rev. Growth |
18.0 |
% Held by Institutions |
51.30 |
|
Forward EPS |
-0.720 |
Gross Profit (p.s.) |
0.139 |
Shares Short (K) |
2930 |
|
Book Value (p.s.) |
0.410 |
EBITDA (p.s.) |
-0.543 |
P/E |
-1.31 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.91 |
|
Profit Margin |
-79.96 |
Operating Cash Flow
(M) |
-14.93 |
P/S |
29995168.00 |
|
Operating Margin |
-78.82 |
Levered Free Cash Flow
(M) |
-7.92 |
P/CF |
-1.51 |
|
|
|
|
|
|
